Venetoclax resistance: mechanistic insights and future strategiesFaustine Ong, Marina Konopleva, Kunhwa Kim|Cancer Drug Resistance|2022Cited by 103
Current Understanding of DDX41 Mutations in Myeloid NeoplasmsKunhwa Kim, Koji Sasaki, Faustine Ong|Cancers|2023Cited by 19
Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasmsKelly S. Chien, Guillermo Garcia‐Manero, Faustine Ong et al.|Cancer Medicine|2024Cited by 11
Outcomes of Patients With Newly Diagnosed AML and HyperleukocytosisFadi Haddad, Tapan M. Kadia, Guillermo Garcia‐Manero et al.|JCO Oncology Practice|2024Cited by 11
MDS-431 Outcomes of Transformation to Acute Myeloid Leukemia after Hypomethylating Agent Therapy in Patients With Myelodysplastic SyndromesKunhwa Kim, Kelly S. Chien, Faustine Ong et al.|Clinical Lymphoma Myeloma & Leukemia|2022Cited by 1